0
Abstract: Slide Presentations |

HYPERHIDROSIS: COMPARATIVE EVALUATION OF THE RESULTS BEFORE AND AFTER SYMPATHECTOMY IN 263 PATIENTS FREE TO VIEW

Evaldo Marchi, MD*; Vivian M. Amioka, MS; Tiago S. Santos, MS; Aline I. Barranco, MS; Gabriel L. Palma, MS; Jose R. Campos, MD
Author and Funding Information

Thoracic Surgery, Medical College of Jundiai, Jundiai, Brazil


Chest


Chest. 2005;128(4_MeetingAbstracts):191S. doi:10.1378/chest.128.4_MeetingAbstracts.191S
Text Size: A A A
Published online

Abstract

PURPOSE:  Primary hyperhidrosis is a condition that leads to functional disability with social and psychological effects. Although several therapeutic options are available to treat this condition, thoracoscopic symphatectomy (TS) has been the treatment of choice because of its safety and long-term control of the disease. However, the ablation of the sympathetic chain is irreversible and may lead to compensatory sweating as the main adverse side effect. In this study we report our experience with video-assisted TS in the treatment of hyperhidrosis.

METHODS:  Two-hundred and sixty-three adult patients underwent TS to treat primary facial, palmar or axillary predominant hyperhidrosis. Patients were evaluated preoperatively for age, body mass index (BMI) and the intensity and degree of social and functional limitations due to the disease (score 1-4), and at 30 days after the intervention for de degree of compensatory sweating, satisfaction with the results (score 1-4) and the need of re-intervention. Statistics: ANOVA.

RESULTS:  Social Limit:*p< 0.001 compared to PalmarFunct Limit:#p< 0.001 compared to Facial and AxillaryComp Sweat:+p< 0.001 compared to Palmar; &p< 0.05 compared to Axillary; ¥p< 0.05 compared to Palmar.

CONCLUSION:  Thoracic sympathectomy is an effective method for the treatment of hyperhidrosis, with a high rate of postoperative satisfaction, low morbidity and low rates of re-operation.

CLINICAL IMPLICATIONS:  TS is an easy, safety method to control hyperhidrosis.

Results

PreoperativePostoperativenageBMIIntensitySocial LimitFunctional LimitCompens SweatSatisfactRe-operatFacial538 ± 1426 ± 34.0 ± 0.03.8 ± 0.4*2.0 ± 0.72.0 ± 0.0+&4.0 ± 0.00 (0%)Palmar11424 ± 823 ± 33.8 ± 0.42.4 ± 1.23.5 ± 0.7#1.0 ± 0.54.0 ± 0.01 (0.9%)Axillary14425 ± 822 ± 33.8 ± 0.43.6 ± 0.5*2.4 ± 1.11.2 ± 0.7¥3.6 ± 0.74 (2.8%)

DISCLOSURE:  Evaldo Marchi, None.

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543